CYTK. 13D showing Amgen owns 7.58% of CYTK just released.
On June 11, 2013, Amgen and the Issuer entered into a Common Stock Purchase Agreement (the “2013 CSPA”), which provided for the sale to Amgen of 8,424,600 shares of the Issuer’s Common Stock (the “Shares”) based on an aggregate purchase price of $10,000,000 and a price per share based on the 10-day trailing average of the closing price of the Issuer’s stock on NASDAQ ending on the last trading day prior to the execution of the 2013 CSPA. Pursuant to the terms of the 2013 CSPA, Amgen received registration rights with respect to the Shares and agreed to certain trading and other restrictions with respect to the Issuer’s Common Stock, as further described in Item 6.
Nice CYTK-This one I alerted some time ago and holding would of been better than trading it for me, glad kept some in IRA-Congrats to all whom banked on it today!